ARID1A and urinary bladder cancer: In line with our assumption, we observed strongly reduced ARID1A mRNA and protein expression in the two bladder cancer cell lines HT1376 and JMSU-1, both harboring a homozygous frameshift mutation in the ARID1A gene as validated by Sanger sequencing (Fig 2D and S1 Fig).